… NLRP3 inflammasome in COVID-19, this review describes the possible pathways of NLRP3
inflammasome activation … the NLRP3 inflammasome in the pathogenesis of COVID-19 and …

… role of NLRP3 inflammasome activation in the severe symptomatic phase of COVID-19 and
… In search for a pathway to relate sustained NLRP3 inflammasome activation in aging we …

… -containing 3 (NLRP3) inflammasome pathway and … COVID-19 and NLRP3 activation
and describe an important role in targeting this pathway for the treatment of severe COVID-19…

… NLRP3 inflammasome appears to be a potential drug target in the treatment of coronavirus
disease 2019 (COVID-19… This manuscript highlights the importance of NLRP3 inflammasome …

… COVID-19 patients. Here we review the literature regarding the mechanism of inflammasome
activation … , it seems that ORF3a promotes NLRP3 inflammasome activation by modulating …

… has been highly speculated, the inflammasome activation and participation in the … NLRP3
inflammasome is activated in response to SARS-CoV-2 infection and it is active in COVID-19, …

… In this review, we focused on the occurrence of NLRP3 inflammasome activation in … interlink
between NLRP3 inflammasome activation and underlying conditions of COVID-19 severity, …

… cytosolic Ca 2+ influx to activate NLRP3 in reconstituted Vero epithelial cells 113,114 .
Another mechanism of NLRP3 inflammasome activation involves direct interactions with viral …

… to inhibit NLRP3 inflammasome activation via interaction … useful in the cytokine storm phase
of COVID-19 [266,267,268]. … activation of NLRP3-dependent inflammasome activation by …

… 2 may be linked to NLRP3 inflammasome activation which has … In SARS-CoV-2 infection,
NLRP3 inflammasome activation … selective inhibitors of NLRP3 inflammasome. To achieve this, …